NCT06916624View on ClinicalTrials.gov

Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 12, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)
Interventions
RADIATION

18F-NY104 PET/CT

The radionuclide ¹⁸F will serve as the tracer in this study. NY104 will be labeled with \[¹⁸F\]AlF to form the ¹⁸F-NY104 injection for use in this research.All participants will undergo ¹⁸F-NY104 PET scan.

Trial Locations (1)

Unknown

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
collaborator

Qianfoshan Hospital

OTHER

collaborator

Weifang People's Hospital

OTHER

collaborator

Zibo Central Hospital

OTHER_GOV

collaborator

Jining Medical University

OTHER

lead

The Affiliated Hospital of Qingdao University

OTHER